MyAverix Finance MyAverix Finance

US · General

Taysha Gene Therapies Inc (TSHA)

Diversified

Taysha Gene Therapies Inc (TSHA) is listed on US in the General sector. Industry: Diversified. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for TSHA

P/E ratio
18.00

Taysha Gene Therapies Inc (TSHA) — FAQ

What is TSHA's P/E ratio?

The price-to-earnings (P/E) ratio for Taysha Gene Therapies Inc (TSHA) is 18.00 (data as of 2026-05-24).

Does Taysha Gene Therapies Inc pay a dividend?

Dividend yield is not available in the current snapshot for Taysha Gene Therapies Inc (TSHA). Check the MyAverix Finance app for the latest dividend data.

What sector is Taysha Gene Therapies Inc in?

Taysha Gene Therapies Inc (TSHA) is classified in the General sector (Diversified industry).

What exchange is TSHA listed on?

TSHA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play